tiprankstipranks
Y-Mabs Therapeutics (YMAB)
NASDAQ:YMAB
US Market
Holding YMAB?
Track your performance easily

Y-Mabs Therapeutics (YMAB) Technical Analysis

527 Followers

Technical Sentiment

Overall Consensus
Sell
6Bullish
1Neutral
15Bearish
Technical Analysis Consensus
Buy
6Bullish
1Neutral
3Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Y-Mabs Therapeutics’s (YMAB) Moving Averages Convergence Divergence (MACD) indicator is -1.05, suggesting Y-Mabs Therapeutics is a Buy.
Y-Mabs Therapeutics’s (YMAB) 20-Day exponential moving average is 7.75, while Y-Mabs Therapeutics’s (YMAB) share price is $6.18, making it a Sell.
Y-Mabs Therapeutics’s (YMAB) 50-Day exponential moving average is 9.55, while Y-Mabs Therapeutics’s (YMAB) share price is $6.18, making it a Sell.

Y-Mabs Therapeutics (YMAB) Pivot Points

Jan 18, 2025, 08:04 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
5.68
5.99
6.19
6.50
6.70
7.01
7.21
Fibonacci
5.99
6.18
6.31
6.50
6.69
6.82
7.01
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Y-Mabs Therapeutics (YMAB) Moving Averages

Jan 18, 2025, 08:04 AM
Period
Simple
Exponential
MA5
6.46Sell
6.53Sell
MA10
7.13Sell
6.97Sell
MA20
7.71Sell
7.75Sell
MA50
10.12Sell
9.55Sell
MA100
12.08Sell
11.00Sell
MA200
12.48Sell
12.14Sell
Y-Mabs Therapeutics’s (YMAB) 10-Day exponential moving average is 6.97, while Y-Mabs Therapeutics’s (YMAB) share price is $6.18, making it a Sell.
Y-Mabs Therapeutics’s (YMAB) 100-Day exponential moving average is 11.00, while Y-Mabs Therapeutics’s (YMAB) share price is $6.18, making it a Sell.
Y-Mabs Therapeutics’s (YMAB) stock price is $6.18 and Y-Mabs Therapeutics’s (YMAB) 50-day simple moving average is 10.12, creating a Sell signal.
Y-Mabs Therapeutics’s (YMAB) stock price is $6.18 and Y-Mabs Therapeutics’s (YMAB) 100-day simple moving average is 12.08, creating a Sell signal.
Y-Mabs Therapeutics’s (YMAB) stock price is $6.18 and Y-Mabs Therapeutics’s (YMAB) 200-day simple moving average is 12.48, creating a Sell signal.

Y-Mabs Therapeutics (YMAB) Technical Indicators

Jan 18, 2025, 08:04 AM
Name
Value
Implied Action
RSI (14)
19.03
Buy
STOCH (9,6)
11.37
Buy
STOCHRSI (14)
11.11
Buy
MACD (12,26)
-1.05
Buy
ADX (14)
32.89
Neutral
Williams %R
-93.49
Buy
CCI (14)
-153.95
Buy
ATR (14)
0.60
-
Ultimate Oscillator
27.91
Sell
ROC
-24.17
Sell
Y-Mabs Therapeutics’s (YMAB) Relative Strength Index (RSI) is 19.03, creating a Buy signal.
Y-Mabs Therapeutics’s (YMAB) Trend Strength Indicator (ADX) is 32.89, creating a Neutral signal.
Y-Mabs Therapeutics’s (YMAB) Commodity Channel Index (CCI) is -153.95, creating a Buy signal.
Y-Mabs Therapeutics’s (YMAB) Price Rate of Change (ROC) is -24.17, creating a Sell signal.

FAQ

Is YMAB a Buy, Hold, or Sell?
Based on YMAB’s technical indicators, YMAB is a Sell.
    What is YMAB’s RSI (14)?
    YMAB’s RSI (14) is 19.03, which suggests YMAB is a Buy.
      What is YMAB’s MACD?
      YMAB’s MACD is -1.05, which suggests YMAB is a Buy.
        What is YMAB’s 5-day moving average?
        YMAB’s 5-day moving average is 6.46, which suggests YMAB is a Sell.
          What is YMAB’s 20-day moving average?
          YMAB 20-day moving average is 7.71, which suggests YMAB is a Sell.
            What is YMAB’s 50-day moving average?
            YMAB’s 50-day moving average is 10.12, which suggests YMAB is a Sell.
              What is YMAB’s 200-day moving average?
              YMAB’s 200-day moving average is 12.48, which suggests YMAB is a Sell.
                What is YMAB’s Williams % R (14)?
                YMAB’s Williams % R (14) is -93.49, which suggests YMAB is a Buy.
                  What is YMAB’s CCI (14)?
                  YMAB’s CCI (14) is -153.95, which suggests YMAB is a Buy.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis